The US Food and Drug Administration (FDA) has approved a new 4-strain seasonal flu vaccine from GlaxoSmithKline plc (GSK), the company announced on Monday. Fluarix Quadrivalent is approved for use in adults, plus children aged 3 and over, to protect them from disease caused by influenza virus...